Albertus van den Bergh
Président chez Revalesio Corp.
Profil
Albertus van den Bergh is currently the Executive Chairman at Revalesio Corp.
He previously worked as the Vice President-Global Customer Solutions at Eli Lilly & Co. He completed his undergraduate degree at Nyenrode Business Universiteit and earned an MBA from Delft University of Technology in 1979.
Postes actifs de Albertus van den Bergh
| Sociétés | Poste | Début |
|---|---|---|
Revalesio Corp.
 Revalesio Corp. Miscellaneous Commercial ServicesCommercial Services Revalesio Corp. develops therapeutics for the treatment of inflammatory diseases through Taylor-Couette-Poiseuille (TCP) flow. The company is headquartered in Tacoma, WA. | Président | 01/01/2019 |
Anciens postes connus de Albertus van den Bergh
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Albertus van den Bergh
| Nyenrode Business Universiteit | Undergraduate Degree |
| Delft University of Technology | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Revalesio Corp.
Revalesio Corp. Miscellaneous Commercial ServicesCommercial Services Revalesio Corp. develops therapeutics for the treatment of inflammatory diseases through Taylor-Couette-Poiseuille (TCP) flow. The company is headquartered in Tacoma, WA. | Commercial Services |
